SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-264451
Filing Date
2019-10-08
Accepted
2019-10-08 16:01:44
Documents
14
Period of Report
2019-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d828061d8k.htm   iXBRL 8-K 34492
2 EX-1.1 d828061dex11.htm EX-1.1 234632
3 EX-5.1 d828061dex51.htm EX-5.1 4796
  Complete submission text file 0001193125-19-264451.txt   461199

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20191003.xsd EX-101.SCH 3067
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20191003_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20191003_pre.xml EX-101.PRE 11406
15 EXTRACTED XBRL INSTANCE DOCUMENT d828061d8k_htm.xml XML 3466
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 191142772
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences